Buy Exelon

Exelon

What is Exelon?

Exelon is a prescription medication that contains the active ingredient rivastigmine. It belongs to the neurology therapeutic area and is classified as an acetylcholinesterase inhibitor. The product is supplied as oral pills in two strengths: 1.5 mg and 3 mg. In the United Kingdom, Exelon is a Prescription-only Medicine (POM) and is authorised by the Medicines and Healthcare products Regulatory Agency (MHRA). The brand is marketed by Novartis and is indicated for the symptomatic treatment of certain types of dementia.

How Exelon Works in the Body

Rivastigmine inhibits the enzymes acetylcholinesterase and butyrylcholinesterase, which are responsible for breaking down the neurotransmitter acetylcholine in the brain. By reducing this breakdown, rivastigmine raises the level of acetylcholine in neuronal synapses. Higher acetylcholine concentrations help improve communication between nerve cells, which can modestly alleviate the cognitive decline associated with Alzheimer’s disease and Parkinson’s disease dementia.

• Onset of action: Clinical effects may become noticeable after several weeks of consistent use.
• Peak effect: Typically observed after 4-12 weeks of therapy.
• Duration: The drug’s effects persist for about 4-6 hours after each dose, which is why it is taken twice daily.

Conditions Treated by Exelon

Exelon is approved in the UK for the symptomatic treatment of mild to moderate dementia in the following conditions:

• Alzheimer’s disease
• Parkinson’s disease dementia

The medication does not cure these conditions but can help improve cognition, daily functioning, and overall quality of life for some patients. Treatment is usually considered when the benefits of increased cholinergic activity outweigh potential side effects.

Patient Suitability and Contraindications

Who Should Use Exelon?

• Adults diagnosed with mild-to-moderate Alzheimer’s disease or Parkinson’s disease dementia.
• Patients who can swallow tablets whole and follow a twice-daily dosing schedule.
• Individuals without severe hepatic or renal impairment, unless dosage adjustments are made under medical supervision.

Absolute Contraindications

• Known hypersensitivity to rivastigmine or any of the tablet excipients.
• Severe liver disease (e.g., Child-Pugh Class C).
• History of severe gastrointestinal ulceration or bleeding.

Relative Contraindications

• Moderate hepatic impairment (Child-Pugh Class B).
• Renal impairment (creatinine clearance <30 mL/min).
• Pre-existing cardiac conduction abnormalities.
• Pregnancy and lactation: rivastigmine is classified as Category B3 in the UK; use only if the potential benefit justifies the potential risk.

Special Populations

• Elderly: Dose titration should be performed cautiously, as older adults are more susceptible to gastrointestinal side effects.
• Patients with swallowing difficulties: Exelon is also available as a transdermal patch, but that formulation is outside the scope of this pill-focused article.

Safety Profile: Side Effects and Interactions

Common Side Effects

• Nausea - often transient, especially during dose escalation.
• Vomiting - may accompany nausea, generally improves with continued use.
• Diarrhoea - watery stools are common in the first weeks.
• Loss of appetite - can lead to mild weight loss.
• Abdominal pain - cramp-like discomfort, usually mild.

These effects are frequently reported by more than 1 % of patients taking rivastigmine.

Serious Adverse Events

• Severe gastrointestinal bleeding - rare but potentially life-threatening; seek immediate medical attention if black tarry stools or vomiting of blood occur.
• Bradycardia or heart block - patients with pre-existing conduction disorders should be monitored closely.
• Seizures - very uncommon; report any sudden convulsions promptly.

Drug Interactions

• Anticholinergic agents (e.g., diphenhydramine, atropine) - may counteract rivastigmine’s effect, reducing therapeutic benefit.
• β-blockers and other heart-rate-lowering drugs - can augment the risk of bradycardia.
• Other cholinesterase inhibitors (e.g., donepezil, galantamine) - concurrent use is not recommended due to additive toxicity.
• Medications affecting hepatic metabolism (e.g., certain antifungals, macrolide antibiotics) - may alter rivastigmine plasma levels; dose adjustment may be required.

Food and Lifestyle Interactions

• Food: Rivastigmine can be taken with or without food, but swallowing tablets with a full glass of water may lessen gastrointestinal upset.
• Alcohol: Moderate consumption is generally permissible, but excessive drinking can increase the risk of nausea and dizziness.
• Driving: The medication can cause dizziness or visual disturbances, especially during dose titration; patients should assess their ability to operate vehicles safely.

Patients should disclose all prescribed medicines, over-the-counter products, and herbal supplements to their prescriber before starting Exelon.

How to Take Exelon

Standard Dosing

• Initiation: 1.5 mg taken twice daily (morning and evening), preferably with meals to minimise stomach irritation.
• Titration: After at least 2 weeks, the dose may be increased to 3 mg twice daily if tolerated and if greater clinical benefit is desired.
• Maximum dose: 3 mg twice daily (based on the available strengths in this article).

Special Population Adjustments

• Renal impairment: For patients with creatinine clearance <30 mL/min, start at 1.5 mg once daily and consider a slower titration schedule.
• Hepatic impairment: In moderate liver disease, a maximum of 3 mg once daily may be sufficient; consult a specialist.
• Elderly: Start low and titrate slowly; monitor for weight loss and dehydration.

Administration of the Pill

• Swallow the tablet whole; do not crush, chew, or split the tablet.
• Take the dose at approximately the same times each day to maintain stable blood levels.
• Store tablets in the original container, tightly closed, at room temperature (15-30 °C), protected from moisture and light.

Missed Dose

• If a dose is missed, take it as soon as remembered unless it is less than 6 hours before the next scheduled dose. In that case, skip the missed dose and continue with the regular schedule. Do not double up.

Overdose

• Symptoms may include severe nausea, vomiting, diarrhoea, abdominal pain, and excessive salivation.
• In the event of suspected overdose, seek emergency medical care; treatment is largely supportive, focusing on gastrointestinal decontamination and symptom management.

Discontinuation

• Stopping Exelon abruptly may lead to a rapid return of dementia symptoms. A gradual taper, typically reducing the dose by 1.5 mg every 1-2 weeks, is recommended under physician guidance.

Monitoring and Follow-Up

• Baseline assessment: Cognitive function (e.g., MMSE), weight, liver function tests, and renal function should be documented before initiating therapy.
• Follow-up visits: Typically scheduled every 4-6 weeks during titration, then every 3-6 months once a stable dose is achieved.
• Laboratory monitoring: Periodic liver enzymes and renal function tests are advised, especially in patients with pre-existing organ impairment.
• Clinical monitoring: Observe for worsening gastrointestinal symptoms, weight loss, or signs of bradycardia. Promptly report any serious adverse events to a healthcare professional.

Storage and Handling

• Keep tablets in the original blister pack until use.
• Store at room temperature (15-30 °C), away from direct sunlight and moisture.
• Do not store in the bathroom or near a kitchen sink.
• Keep out of reach of children and pets; consider a locked medicine cabinet.
• Dispose of unused tablets according to local pharmacy take-back schemes or the NHS’s “Safely Discard Medicines” guidelines.

Medication-Specific Glossary

Acetylcholinesterase Inhibitor

A drug that blocks the enzyme acetylcholinesterase, preventing the breakdown of acetylcholine and thereby enhancing cholinergic transmission in the brain.

Butyrylcholinesterase

An enzyme similar to acetylcholinesterase that also hydrolyses acetylcholine; rivastigmine inhibits both, providing a broader increase in cholinergic activity.

Titration

The gradual adjustment of a medication’s dose to achieve optimal therapeutic effect while minimising side effects.

Cognitive Decline

A gradual loss of memory, thinking, and decision-making abilities, characteristic of dementia syndromes.

Bradycardia

A slower than normal heart rate (usually <60 beats per minute), which can be exacerbated by cholinergic drugs.

Medical Disclaimer

This article provides educational information about Exelon and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.